Wie hoch ist der Preis für PCL, Inc. (241820)

Preis für PCL, Inc. (241820) ist $0.21291741

Wie hoch ist die Marktkapitalisierung für PCL, Inc. (241820)

Marktkapitalisierung für PCL, Inc. (241820) ist $12.07M

PCL, Inc. (241820) Aktiensplits

PCL, Inc. specializes in providing sophisticated multiplex in vitro diagnostic (IVD) solutions, encompassing both diagnostic products and specialized platform services. The company's primary offerings include comprehensive multiplex kits designed to detect antibodies to Human Immunodeficiency Virus (HIV) types 1 and 2, Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), and Human T-lymphotropic Virus (HTLV) types 1 and 2. These kits also identify specific antigens such as HIV p24, HCV core, and HBV surface markers in human serum or plasma samples. In addition to these, PCL markets Ai, a rapid diagnostic test kit capable of typing influenza A and B strains; Cancer6, a screening kit for multiple tumor biomarkers; and the sciLINER LATERAL FLOW DISPENSER, an advanced dispensing device for membrane materials featuring active visual drop volume control. Beyond its product portfolio, PCL offers valuable platform services. These include a sol-gel spotting service, which immobilizes client-specified materials using the proprietary SolB reagent, and an SG ID service, providing customers with identified molecules of interest securely immobilized within the SolB reagent. PCL, Inc. is headquartered in Seoul, South Korea.

Jahr	Aktien-Split	Multiplikator	Kumulierter Multiplikator
2023-09-14	3:1	x3	x3.363
2023-07-14	1121:1000	x1.121	x1.121

Jahr

Aktien-Split

Multiplikator

Kumulierter Multiplikator

2023-09-14

3:1

x3.363

2023-07-14

1121:1000

x1.121

Unternehmen	Anzahl der Aktiensplits	Kumulierter Multiplikator	Land
Abbott Laboratories ABT.US	9	x285	US
Stryker Corporation SYK.US	9	x162	US
Medtronic plc MDT.US	7	x127	IE
Boston Scientific Corporation BSX.US	2	x4	US
Edwards Lifesciences Corporation EW.US	3	x12	US

Unternehmen

Anzahl der Aktiensplits

Kumulierter Multiplikator

Land